Vagifem

Short answer “Bioidentical” hormones are molecules formulated to be chemically identical to the hormones your body makes (usually estradiol and progesterone). “Standard” HRT (hormone replacement therapy) includes both bioidentical (FDA‑approved) products and older synthetic or animal‑derived products; the main practical difference most people face is whether the product is an FDA‑reviewed drug or a custom‑compounded preparation from a pharmacy. There’s no good evidence that custom‑compounded “bioidentical hormone therapy” is safer or more effective than FDA‑approved HRT. Compounded products can have variable potency and lack FDA oversight. What each term means Bioidentical hormones: chemically identical to human hormones (example: 17β‑estradiol, micronized progesterone). These can be made as FDA‑approved products (tablets, patches, gels, vaginal rings) or as custom compounds from compounding pharmacies. Standard HRT: a broader category that includes FDA‑approved estradiol products (patches, gels, pills) and FDA‑approved micronized progesterone, synthetic progestins (e.g., medroxyprogesterone acetate) and animal‑derived estrogens (e.g., conjugated equine estrogens). These are manufactured drugs with standardized dosing and safety testing. Examples (brand names and why they matter) FDA‑approved, bioidentical examples: Prometrium (micronized progesterone) — FDA‑approved bioidentical progesterone used to protect the uterus when systemic estrogen is given. Estradiol patches/gels: Vivelle‑Dot, Climara, Alora — deliver 17β‑estradiol transdermally and have standardized dosing. Bijuva — an FDA‑approved combined oral capsule containing estradiol and progesterone (bioidentical combination). Vaginal products: Estrace cream, Vagifem tablets, Estring/Femring (vaginal ring/locally acting estradiol) — useful for local symptoms with lower systemic exposure. Non‑bioidentical / synthetic examples: Premarin (conjugated equine estrogens) — animal‑derived estrogen mixture, historically common. Provera (medroxyprogesterone acetate) — synthetic progestin. Compounded “bioidentical” creams or troches: made by compounding pharmacies to a custom dose. These are not FDA‑approved and product strength/purity can vary. If you choose this route, use a PCAB‑accredited compounding pharmacy (look up PCAB accreditation). Examples of well‑known compounding suppliers/pharmacies in the U.S. include Wedgewood Pharmacy and Fagron (as suppliers/compounding networks) — but check current accreditation and reputation locally. Safety, evidence, and regulation FDA‑approved HRT products have known dosages, standardized manufacturing, and have been evaluated for quality and safety. Long‑term risks (breast cancer, cardiovascular disease, stroke, blood clots) depend on the type of hormone, dose, route (oral vs transdermal), whether progesterone is given, and your personal risk factors. The Women’s Health Initiative (WHI) showed increased risks with combined conjugated equine estrogen + medroxyprogesterone in older participants. Risk profiles differ with estradiol vs conjugated equine estrogens and with micronized progesterone vs synthetic progestins. Compounded bioidenticals: proponents claim “natural” = safer, but there’s no high‑quality evidence that compounded BHRT reduces long‑term risks. Because compounded products aren’t FDA‑reviewed, potency and purity can be inconsistent and they may lack safety data. Testing and monitoring Beware of clinics that base dosing on saliva tests or single spot hormone levels — hormone levels fluctuate and those tests are not reliable for routine dosing. Appropriate approach: evaluate symptoms, medical history, family history (breast cancer, clotting disorders), baseline screening (mammogram, blood pressure, lipids, glucose as needed), then choose a therapy and monitor symptoms and side effects regularly. Use the lowest effective dose for the shortest needed time, and use uterine protection (progesterone or a progestin) if you have a uterus and take systemic estrogen. Practical guidance / when to prefer one option If you want the assurance of standardized dosing and known safety data, choose FDA‑approved products (e.g., estradiol patches, oral estradiol, Prometrium, Bijuva). Consider local vaginal estrogen (Estrace cream, Vagifem, Estring) for primarily vaginal dryness/urginal symptoms — these have lower systemic exposure. If you have unusual needs (allergies to excipients, very specific dose requests), a compounding pharmacy can be considered — but insist on a reputable, PCAB‑accredited pharmacy and understand the tradeoffs (no FDA approval, variable evidence). Discuss the choice with a clinician experienced in menopause/HRT care (board‑certified gynecologist or endocrinologist). Trusted resources: North American Menopause Society (NAMS), Mayo Clinic, Cleveland Clinic for patient information and evidence‑based guidance. Bottom line “Bioidentical” describes the molecular structure of the hormone; the clinically important distinction is whether the product is an FDA‑approved, standardized medication or a custom, non‑FDA‑regulated compounded product. FDA‑approved bioidentical options (Prometrium, estradiol patches/creams, Bijuva) give predictable dosing and safety data; compounded BHRT may be useful in select cases but carries more uncertainty. Talk with a clinician about your symptoms, risks, and monitoring plan before starting HRT.

Mentioned in position 7 of 13

Short answer Start by talking with a clinician (your gynecologist or a menopause specialist) about your symptoms, health risks and goals. In most cases I’d ask first about FDA‑approved, “bioidentical” estradiol and progesterone options (transdermal estradiol patch, low‑dose vaginal estrogen for local symptoms, and micronized progesterone for endometrial protection). These have known dosing, manufacturing oversight and better safety data than custom‑compounded products. Consider compounded (“BHRT”) only after a careful discussion about risks/benefits and only from a PCAB‑accredited compounding pharmacy if you and your clinician decide you truly need a custom formulation. What “BHRT” and “traditional HRT” mean Traditional HRT usually refers to FDA‑approved products (oral or transdermal estradiol; conjugated estrogens; progestins such as medroxyprogesterone acetate; micronized progesterone). Many FDA‑approved estradiol and progesterone products are chemically identical to human hormones (“bioidentical”). “BHRT” commonly means custom‑compounded hormones made to order (variable doses/combination/forms). These are not FDA‑approved, have variable quality among pharmacies, and have limited long‑term safety data. Key pros/cons FDA‑approved HRT (recommended first): Pros: regulated manufacturing, consistent dosing, clinical trial and safety data, insurance coverage often available. Cons: fixed doses/forms may not suit every patient’s preference. Compounded BHRT: Pros: customized dose/form (cream, troche, unusual combos) — sometimes helpful if you cannot tolerate standard formulations. Cons: less regulation, variable potency/purity, limited evidence on long‑term safety and efficacy, insurance usually won’t cover. Specific products to consider asking about Transdermal estradiol patches (lower VTE risk than some oral estrogens): Vivelle‑Dot, Climara. Oral estradiol (bioidentical): Estrace. Vaginal/local products for genitourinary symptoms: Vagifem (tablet), Estring (ring), low‑dose estradiol creams/gels. Micronized progesterone (bioidentical for endometrial protection): Prometrium. Avoid automatically requesting “natural” or unspecified BHRT — ask whether the prescription is FDA‑approved and what evidence supports it. When BHRT might be reasonable You’ve tried standard, FDA‑approved therapy and have side effects or need a dose/form not commercially available; or you have a documented intolerance to available preparations. Even then: insist on a PCAB‑accredited compounding pharmacy and a clear plan for monitoring and follow‑up. Where to go / whom to ask Start with your primary care doctor or gynecologist. If your case is complex or you want specialized care, see a menopause clinician. Use these resources: North American Menopause Society (NAMS) — “Find a Menopause Practitioner” tool to locate NAMS‑certified clinicians. NAMS clinicians are experienced in individualized HRT decisions. Major academic centers/menopause clinics: Mayo Clinic, Cleveland Clinic, UCSF Menopause Program — good if you want a second opinion or complex-risk assessment. If you choose compounding, use a PCAB‑accredited compounding pharmacy (search PCAB accreditee list) — this reduces but does not eliminate quality concerns. What to ask your clinician (bring this list) What are the benefits and risks for me specifically (age, family history of breast cancer, clotting/cardiac history)? Which route is best (patch, pill, topical, vaginal) and why? Can you explain the evidence comparing transdermal estradiol + micronized progesterone vs oral estrogen + synthetic progestin for my risks? If I want “bioidentical” hormones, which FDA‑approved options are bioidentical? If you suggest compounded BHRT, why and from which accredited pharmacy? How will we monitor symptoms, side effects, and safety (follow‑up schedule, labs, mammograms)? Bottom line recommendation Ask first for a personalized plan from a knowledgeable clinician and consider FDA‑approved, bioidentical estradiol (prefer transdermal if clot risk is a concern) plus micronized progesterone if you have a uterus. Reserve compounded BHRT only after careful discussion and, if used, get it from a PCAB‑accredited pharmacy with close follow‑up. If you want, tell me: your age, menopausal symptoms, major medical history (breast clotting disease, heart disease, stroke, liver disease, cancer), and whether you prefer pills, patches, or topical treatments — I can suggest a specific conversation script and which exact product to request.

Mentioned in position 4 of 10

Short answer: Bioidentical hormones can be safe and effective when prescribed and monitored by a clinician, but the safety depends on which products are used, who prescribes them, and your personal health risks. Major medical societies caution against custom-compounded “bioidentical” mixtures and recommend FDA‑approved formulations when hormone therapy is needed. Key points doctors and medical societies emphasize “Bioidentical” simply means the molecule is chemically identical to human hormones (e.g., estradiol, progesterone). That label does not guarantee safety or superiority. FDA‑approved bioidentical products (standard prescription estradiol, micronized progesterone) are regulated for dose, purity and labeling. These are the preferred option for most clinicians. Custom-compounded BHRT made by compounding pharmacies is a concern because of inconsistent dosing, lack of standard testing, and weak evidence for claimed advantages. The FDA, ACOG, Endocrine Society and North American Menopause Society (NAMS) have warned about these issues. Risks seen with hormone therapy (both conventional and bioidentical) include increased risk of blood clots, stroke, and — depending on type/duration — possible effects on breast cancer risk and cardiovascular outcomes. Benefits include relief of hot flashes, vaginal symptoms, and bone protection. Individual risk/benefit depends on age, years since menopause, personal/family history of clotting, breast cancer, heart disease, etc. Practical clinical points doctors use If you have a uterus, you need progestogen with systemic estrogen to prevent endometrial hyperplasia. Transdermal estradiol (patches/gels) is often chosen because some evidence suggests lower risk of venous thromboembolism than oral estrogen. Micronized progesterone (versus some synthetic progestins) is preferred by many clinicians for certain safety/tolerability reasons. Routine saliva hormone testing to dose BHRT is not supported by evidence; serum testing and symptom-guided dosing are usual approaches. Testosterone for women can help low libido in selected cases but is generally off‑label and requires specialist oversight; compounded testosterone is commonly used but evidence is limited. FDA‑approved products commonly used (examples clinicians often prescribe) Estradiol (oral): Estrace — FDA‑approved estradiol tablet for menopausal symptoms. Estradiol patches: Vivelle‑Dot, Climara, Alora — transdermal patches give steady dosing and may lower clot risk. Local vaginal products: Estring (ring), Vagifem (vaginal tablet) — treat genitourinary symptoms with low systemic exposure. Micronized progesterone: Prometrium — an FDA‑approved “bioidentical” progesterone many doctors prefer. Testosterone: no widely accepted FDA product labeled for general female libido therapy in the U.S.; some clinicians prescribe low‑dose male formulations off‑label or refer to specialists. Services and resources to consider See a menopause specialist or a clinician trained in hormone management: centers at Mayo Clinic, Cleveland Clinic, or a NAMS‑recognized menopause practitioner are good choices. NAMS (North American Menopause Society) — evidence‑based guidance and clinician directory. If you prefer telemedicine, look for telehealth clinics with certified menopause providers (e.g., some services within Maven Clinic or large academic centers’ telehealth programs). What you can do next Talk with your primary care doctor, gynecologist or a menopause specialist about symptoms and your health history (clotting, heart disease, breast cancer). Ask for FDA‑approved options first (estradiol and micronized progesterone) and discuss routes (transdermal vs oral). Avoid compounded BHRT unless there is a clear medical reason and the compounding pharmacy is accredited and your prescriber documents why a custom product is necessary. Get baseline screening (mammogram as appropriate, blood pressure, discuss clotting history) and plan follow‑up to monitor benefit and side effects. If you want, tell me your age, symptoms, medical history (especially personal/family clotting, breast cancer, cardiovascular disease), and whether you’ve used hormones before — I can give more tailored information and suggest specific questions to bring to your clinician.

Mentioned in position 6 of 10

Short answer BHRT = bioidentical hormone replacement therapy. It means giving hormones that are chemically identical to the hormones your body makes (for example 17β‑estradiol, progesterone, testosterone) to treat symptoms of hormone deficiency. Whether you “need” it depends on your symptoms, medical history, and risks — discuss this with a clinician. What BHRT is (brief) “Bioidentical” refers to the chemical structure being the same as human hormones (not necessarily that it’s safer). BHRT can be delivered as FDA‑approved products (estradiol patches, micronized progesterone capsules, transdermal testosterone products, vaginal estrogen tablets/creams/rings) or as custom‑compounded preparations (creams, pellets, troches). Common targets: menopausal/perimenopausal symptoms (hot flashes, night sweats), vulvovaginal atrophy, sexual dysfunction, and symptomatic low testosterone in men. When BHRT might help Moderate–severe vasomotor symptoms (hot flashes/night sweats) that affect quality of life. Genitourinary syndrome of menopause (vaginal dryness, painful intercourse) — local vaginal estrogen often works well. Premature ovarian insufficiency or surgical menopause (younger people often benefit from hormonal replacement). Men with documented symptomatic low testosterone (confirmed by morning labs and appropriate evaluation). How clinicians decide (testing and assessment) Start with a symptom history, menstrual pattern/age, and medical risk assessment (breast cancer history, clotting disorders, CVD, liver disease, etc.). Common labs: for women — FSH and estradiol (sometimes); for men — morning total testosterone, maybe free testosterone, LH, prolactin, PSA and hematocrit before/during therapy. Beware: saliva hormone tests are not reliable for guiding systemic therapy; blood tests are preferred. You don’t always need labs if a woman is >50 with classic menopausal symptoms; labs are more helpful in atypical cases or younger patients. Benefits vs risks (important) Benefits: relief of hot flashes, improved sleep/mood for some people, vaginal symptom relief, prevention of bone loss if indicated. Risks: similar to conventional HRT — possible increased risk of thromboembolism, stroke, and (depending on hormone type and duration) breast cancer; risk depends on age, dose, route (transdermal estrogen has lower VTE risk than oral), and whether progesterone is used in women with a uterus. Compounded BHRT has less regulatory oversight and variable dosing/purity; safety and efficacy data are more limited. Pellet therapy and unmonitored dosing are associated with higher adverse-event concerns in some reports. Practical guidance — how to proceed Make an appointment with a clinician experienced in menopause or hormone therapy (OB/GYN, reproductive endocrinologist, internist trained in menopause). You can search for a NAMS Certified Menopause Practitioner (NCMP) through the North American Menopause Society (NAMS). Discuss symptoms, medical history, and your goals. Ask about nonhormonal options if you have contraindications. If hormone therapy is appropriate, prefer FDA‑approved, standard formulations first (they have known dosing, quality control, and safety data). Consider transdermal estradiol if you have clotting risk. If considering compounded BHRT, ask why a standard FDA product won’t work, insist on blood testing (not saliva) and on using a reputable, licensed compounding pharmacy that follows USP standards. Be aware of limited oversight and evidence. Specific products and resources (examples) FDA‑approved bioidentical options: estradiol patches (Vivelle‑Dot, Climara), estradiol gels (EstroGel, Divigel), vaginal products (Vagifem tablets, Estrace cream, Estring ring), micronized progesterone (Prometrium). For male testosterone replacement: AndroGel, Testim, Axiron (prescription testosterone products — use requires proper testing and monitoring). Trusted information and clinician search: North American Menopause Society (menopause.org), Endocrine Society guidelines, Mayo Clinic and Cleveland Clinic patient pages. Labs: common national labs (Quest Diagnostics, LabCorp) for reliable serum testing. When not to use BHRT Active, untreated breast cancer or certain other estrogen‑sensitive cancers, active blood clots, unexplained vaginal bleeding, pregnancy. Decisions should be individualized for people with history of breast cancer — discuss risks with an oncologist. If you want next steps Tell me: your age, sex, main symptoms, any major medical history (breast cancer, clotting, heart disease), and whether you’ve had any hormone tests — I can suggest what to ask your clinician and which labs would be reasonable.

Mentioned in position 5 of 14